Affymax (AFFY) Announces Another Data Monitoring Committee Review of Phase 3 Hematide Program
Tweet Send to a Friend
Affymax, Inc. (Nasdaq: AFFY) announced that the independent Data Monitoring Committee, which provides oversight for the Phase 3 program for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
